Výsledky vyhledávání - deJesus, Edwin

Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in... Autor Rolle, Charlotte-Paige, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

Získat plný text Získat plný text Získat plný text

Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced, patients liv... Autor Rolle, Charlotte-Paige, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

Získat plný text Získat plný text Získat plný text

2482. Clinical Outcomes of Once-Daily Darunavir in Treatment-Experienced Patients with Darunavir Resistance Associated Mutations Through 48 Weeks of Treatment Autor Rolle, Charlotte-Paige M, Marquez, Omar, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

Získat plný text Získat plný text

Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV Autor Rolle, Charlotte-Paige, Nguyen, Vu, Patel, Kiran, Cruz, Dan, DeJesus, Edwin, Hinestrosa, Federico

Získat plný text Získat plný text Získat plný text

661. Ibalizumab Efficacy and Safety Through 48 Weeks of Treatment: Results of an Expanded Access Protocol (TMB-311) Autor Emu, Brinda, DeJesus, Edwin, Berhe, Mezgebe, Leider, Jason, Creticos, Catherine, Weinheimer, Steve, Cohen, Zvi

Získat plný text Získat plný text

1012. Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected virologically-suppressed older adults in a real-... Autor Rolle, Charlotte-Paige M, Nguyen, Vu, Patel, Kiran, Cruz, Dan, Hinestrosa, Federico, DeJesus, Edwin

Získat plný text Získat plný text

889. Early Discontinuations and Adverse Events Among Treatment-Naïve Patients Initiating Integrase Inhibitors in a Real-world Setting Autor Rolle, Charlotte-Paige M, Castano, Jamie, Nguyen, Vu, Patel, Kiran, Hinestrosa, Federico, DeJesus, Edwin

Získat plný text Získat plný text

Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data Autor Rodriguez, Allan E, DeJesus, Edwin, Williams, Vanessa, Irlbeck, David, Ross, Lisa, Ha, Belinda, Lancaster, Charles T

Získat plný text Získat plný text Získat plný text

Safety and Efficacy of Enfuvirtide in Combination with Darunavir-Ritonavir and an Optimized Background Regimen in Treatment-Experienced Human Immunodeficiency Virus-Infected Patien... Autor DeJesus, Edwin, Gottlieb, Michael S., Gathe, Joseph C., Greenberg, Michael L., Guittari, Carol Jean, Zolopa, Andrew R.

Získat plný text Získat plný text Získat plný text

Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-In... Autor Jacobson, Jeffrey M., Kuritzkes, Daniel R., Godofsky, Eliot, DeJesus, Edwin, Larson, Jeffrey A., Weinheimer, Steven P., Lewis, Stanley T.

Získat plný text Získat plný text Získat plný text

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults Autor DeJesus, Edwin, Saleh, Soundos, Cheng, Sue, van der Mey, Dorina, Becker, Corina, Frey, Reiner, Unger, Sigrun, Mueck, Wolfgang

Získat plný text Získat plný text Získat plný text

2486. Clinical Outcomes of Patients Treated with Dolutegravir Functional Monotherapy or Dolutegravir plus an Active Non-cytosine Nucleoside Analog: A Retrospective Observational Co... Autor Rolle, Charlotte-Paige M, Bryant, Beth, Tucker, Colton J, Camila Castro, Maria, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin

Získat plný text Získat plný text

1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants Autor Towner, William, DeJesus, Edwin, Schrader, Shannon, De Vente, Jerome, McGary, Colleen, Zogheib, Mohammed, Weinheimer, Steven, Mesquita, Pedro

Získat plný text Získat plný text

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice... Autor Kumar, Princy N, Salvato, Patricia, LaMarca, Anthony, DeJesus, Edwin, Patel, Parul, McClernon, Daniel, Florance, Allison, Shaefer, Mark S

Získat plný text Získat plný text Získat plný text

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice Autor Lackey, Philip, Mills, Anthony, Carpio, Felix, Hsu, Ricky, DeJesus, Edwin, Pierone, Gerald, Henegar, Cassidy, Fusco, Jennifer, Fusco, Gregory, Wohlfeiler, Mike

Získat plný text Získat plný text Získat plný text

Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects Autor DeJesus, Edwin, Piliero, Peter J., Summers, Kim, Wire, Mary Beth, Stein, Daniel S., Masterman, Amanda, Lou, Yu, Min, Sherene S., Shelton, Mark J.

Získat plný text Získat plný text Získat plný text

A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus Autor Thompson, Melanie, Saag, Michael, DeJesus, Edwin, Gathe, Joseph, Lalezari, Jay, Landay, Alan L., Cade, Jerry, Enejosa, Jeffrey, Lefebvre, Eric, Feinberg, Judith

Získat plný text Získat plný text Získat plný text

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults Autor Gallant, Joel E., Thompson, Melanie, DeJesus, Edwin, Voskuhl, Gene W., Wei, Xuelian, Zhang, Heather, White, Kirsten, Cheng, Andrew, Quirk, Erin, Martin, Hal

Získat plný text Získat plný text Získat plný text

Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide Autor Sax, Paul E., DeJesus, Edwin, Crofoot, Gordon, Ward, Douglas, Benson, Paul, Dretler, Robin, Mills, Anthony, Brinson, Cynthia, Wei, Xuelian, Collins, Sean E., Cheng, Andrew

Získat plný text Získat plný text Získat plný text

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT Autor Smith, Kimberly Y, Weinberg, Winkler G, DeJesus, Edwin, Fischl, Margaret A, Liao, Qiming, Ross, Lisa L, Pakes, Gary E, Pappa, Keith A, Lancaster, C Tracey

Získat plný text Získat plný text Získat plný text